Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)

ClinicalTrials.gov ID: NCT03630952

Public ClinicalTrials.gov record NCT03630952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 10:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects With Neovascular Age-Related Macular Degeneration (AMD) (PANDA-2)

Study identification

NCT ID
NCT03630952
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Chengdu Kanghong Biotech Co., Ltd.
Industry
Enrollment
1,157 participants

Conditions and interventions

Interventions

  • 0.5 mg Conbercept Intravitreal Injection Biological
  • 1.0 mg Conbercept Intravitreal Injection Biological
  • 2.0 mg Aflibercept Intravitreal Injection Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2018
Primary completion
Sep 9, 2020
Completion
May 18, 2021
Last update posted
Jun 22, 2021

2018 – 2021

United States locations

U.S. sites
69
U.S. states
29
U.S. cities
64
Facility City State ZIP Site status
Kanghong Investigative Site Phoenix Arizona 85020
Kanghong Investigative Site Phoenix Arizona 85021
Kanghong Investigative Site Springdale Arkansas 72762
Kanghong Investigative Site Arcadia California 91006
Kanghong Investigative Site Arcadia California 91007
Kanghong Investigative Site Bakersfield California 93309
Kanghong Investigative Site Encino California 91436
Kanghong Investigative Site Glendale California 91203
Kanghong Investigative Site Glendora California 91741
Kanghong Investigative Site Huntington Beach California 92647
Kanghong Investigative Site Pasadena California 91107
Kanghong Investigative Site Poway California 92064
Kanghong Investigative Site Redlands California 92373
Kanghong Investigative Site Redlands California 92374
Kanghong Investigative Site Riverside California 92505
Kanghong Investigative Site San Francisco California 94109
Kanghong Investigative Site Santa Barbara California 93013
Kanghong Investigative Site Colorado Springs Colorado 80909
Kanghong Investigative Site Waterford Connecticut 06385
Kanghong Investigative Site Boynton Beach Florida 33426
Kanghong Investigative Site Bradenton Florida 34209
Kanghong Investigative Site Miami Florida 33126
Kanghong Investigative Site Miami Florida 33143
Kanghong Investigative Site Stuart Florida 34994
Kanghong Investigative Site Winter Haven Florida 33880
Kanghong Investigative Site Atlanta Georgia 30328
Kanghong Investigative Site Augusta Georgia 30909
Kanghong Investigative Site Marietta Georgia 30060
Kanghong Investigative Site Elmhurst Illinois 60126
Kanghong Investigative Site Indianapolis Indiana 46290
Kanghong Investigative Site New Albany Indiana 47150
Kanghong Investigative Site Leawood Kansas 66211
Kanghong Investigative Site Springfield Massachusetts 01107
Kanghong Investigative Site Grand Rapids Michigan 49546
Kanghong Investigative Site Traverse City Michigan 49686
Kanghong Investigative Site St Louis Missouri 63128
Kanghong Investigative Site Reno Nevada 89502
Kanghong Investigative Site Northfield New Jersey 08205
Kanghong Investigative Site Teaneck New Jersey 07666
Kanghong Investigative Site Albuquerque New Mexico 87109
Kanghong Investigative Site Brooklyn New York 11201
Kanghong Investigative Site Great Neck New York 11021
Kanghong Investigative Site Liverpool New York 13088
Kanghong Investigative Site Shirley New York 11967
Kanghong Investigative Site Asheville North Carolina 28803
Kanghong Investigative Site Winston-Salem North Carolina 27157
Kanghong Investigative Site Youngstown Ohio 44505
Kanghong Investigative Site Oklahoma City Oklahoma 73104
Kanghong Investigative Site Medford Oregon 97504
Kanghong Investigative Site Portland Oregon 97225
Kanghong Investigative Site Springfield Oregon 97477
Kanghong Investigative Site Camp Hill Pennsylvania 17011
Kanghong Investigative Site Kingston Pennsylvania 18704
Kanghong Investigative Site Ladson South Carolina 29456
Kanghong Investigative Site Rapid City South Dakota 57701
Kanghong Investigative Site Arlington Texas 76012
Kanghong Investigative Site Austin Texas 78705
Kanghong Investigative Site Austin Texas 78731
Kanghong Investigative Site Bellaire Texas 77401
Kanghong Investigative Site Dallas Texas 75231
Kanghong Investigative Site Fort Worth Texas 76102
Kanghong Investigative Site Kingwood Texas 77339
Kanghong Investigative Site McAllen Texas 78503
Kanghong Investigative Site Midland Texas 79706
Kanghong Investigative Site Temple Texas 76502
Kanghong Investigative Site Salt Lake City Utah 84107
Kanghong Investigative Site Burlington Vermont 05401
Kanghong Investigative Site Charlottesville Virginia 22903
Kanghong Investigative Site Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03630952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03630952 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →